XML 47 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
Collaboration Agreements Schedule of Significant Changes in Deferred Revenue Balances - Antibody Collaboration (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Disaggregation of Revenue [Line Items]    
Increase (decrease) in deferred revenue $ (84,238) $ (10,655)
Sanofi Collaboration Agreement, Antibody    
Disaggregation of Revenue [Line Items]    
Increase (decrease) in deferred revenue 108,359  
Revenue recognized that was included in deferred revenue at the beginning of the period $ (55,135)